33
Participants
Start Date
April 30, 2006
Primary Completion Date
October 31, 2011
Study Completion Date
April 30, 2012
Dronabinol
Oral route, 5mg PO 2x daily before and during 2 cycles of chemotherapy,2.5mg PO every night when not on chemotherapy
Preston Robert Tisch Brain Tumor Center at Duke University Medical Center, Durham
Lead Sponsor
Solvay Pharmaceuticals
INDUSTRY
Duke University
OTHER